ALA-1300
CNS Disorder (Preclinical)
PreclinicalActive
Key Facts
About Alar Pharmaceuticals
Taiwanese biotech delivering long‑acting injectables for CNS and chronic pain via the In‑Relar platform.
View full company profileTherapeutic Areas
Other CNS Disorder (Preclinical) Drugs
| Drug | Company | Phase |
|---|---|---|
| ALA-2000 | Alar Pharmaceuticals | Preclinical |